期刊文献+

糖尿病肾病患者血栓调节蛋白水平变化 被引量:4

Levels of Plasma Thrombomodulin(TM) in Patients with Diabetes Nephropathy
暂未订购
导出
摘要 目的 探讨血浆血栓调节蛋白 (TM)在糖尿病肾病中的变化及其意义。方法 检测 6 8例 2型糖尿病患者血浆 TM与内皮素 (ET)、血管性假血友病因子 (v WF)的水平 ,并与 30例正常人进行比较。结果 糖尿病组血浆TM水平明显高于正常对照组 ,临床糖尿病肾病 (CDN)组的血浆 TM水平明显高于早期糖尿病肾病 (EDN)组及单纯糖尿病 (SDM)组。血浆 TM水平与 ET、v WF水平及尿白蛋白排泄率均呈显著正相关。结论血浆 TM水平对糖尿病肾病的早期诊断及判断其血管内皮损伤程度有重要意义。 Objective To study the changes and significance of plasma TM levels in patients with diabetic nephropathy.Methods The levels of plasma TM,endothelin(ET) and von Willebrand factor(vWF) were measured in 68 cases with type 2 diabetes mellitus and 30 normal controls.Results The levels of plasma TM were markedly elevated in diabetes mellitus group than in normal control group.The plasma TM levels in CDN group were significantly higher than those in SDM and EDN groups.Plasma TM had positive correlations to urinary albumin excretion rate,ET and vWF,respectively.Conclusions The measurement of plasma TM has an important meaning in evaluating the early diagnosis and severity of type 2 diabetes nephropathy.
出处 《中国慢性病预防与控制》 CAS 2001年第6期253-255,共3页 Chinese Journal of Prevention and Control of Chronic Diseases
关键词 糖尿病肾病 血栓调节蛋白 内皮素 血管性假血友病因子 Diabetic nephropathy Thrombomodulin Endothelin von Willebrand factor
  • 相关文献

参考文献6

二级参考文献26

  • 1周丽诺,朱禧星.Ⅱ型糖尿病人血浆中内皮素-Ⅰ含量增值的临床意义[J].上海医科大学学报,1994,21(6):437-439. 被引量:12
  • 2曾正陪,唐丹,孙梅励,关炳江,吕朝,王.血浆内皮素与糖尿病血管病变的关系[J].中华内科杂志,1994,33(7):467-469. 被引量:78
  • 3张晓黎 王桂兰 等.一氧化氮在糖尿病性肾病中的变化及其临床意义[J].中华内分泌代谢杂志,1998,14:18-20.
  • 4张晓黎,中华内分泌代谢杂志,1998年,14卷,18页
  • 5张原力,中华心血管病杂志,1998年,260卷,89页
  • 6周丽诺,上海医科大学学报,1994年,21卷,437页
  • 7曾正陪,中华内科杂志,1994年,33卷,467页
  • 8Hu R M,Diabetes,1993年,42卷,351页
  • 9Sadler IE. Thrombomodulin structure and function 〔J〕.Thromb Hacmost,1997,78:392~395.
  • 10Aso Y,Inukai T,Takemura Y,et al.Mechanisms of elevation of serum and urinary concentrations of soluble thrombomodulin in diabetic patients:possible application as a marker for vascular endothelial injury 〔J〕.Metabolism,1998,47:362~365.

共引文献2444

同被引文献35

  • 1汪钟.现代血栓病学[M].北京:中国医科大学协和医科大学联合出版社,1996.192-199.
  • 2内科学.叶任高主编(第5版)[M].北京:人民卫生出版社,2000.569-570.
  • 3Sumida Y, Wadar L, Fujii M, et al. Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin dependent diahetes mellitus.Blood Coagul Fibrinolgsis, 1997,8:303-307.
  • 4Aso Y, Inukai T, Takemura Y. Mechanisms of elevation of serum and urinary concentrations of soluble thrombomodulin in diabetic patients possible applications as amarker for vascular endothelial injury.Metabolism, 1998,47:362-365.
  • 5Nawata K, Sohmiya M, Kawaguchi M, et al. Increased resting metabolic rate in patients with type 2 diabetes mellitus accompanied by advanced diabetic nephropathy. Metabolism 2004;53(11): 1395-8
  • 6Galajda P, Martinka E, Mokan M, et al. Endothelial markers in diabetes mellitus [J]. Thromb Res,1997, 85(1):63-65
  • 7Yano Y, Kitagawa N, Gabazza EC, et al. Increased plasma thrombin-activatable fibrinolysis inhibitor levels in normotensive type 2 diabetic patients with microalbuminuria [J]. Clin Endocrinol Metab, 2003, 88(2):736-741.
  • 8Tanaka A. Thrombomodulin in blood [J]. Nippon Rinsho, 2002, 60 (suppl 8):469-474.
  • 9Sadler JE. Thrombomodulin structure and function [J]. Thromb Haemost, 1997, 78(1):392-395.
  • 10Hofmann MA, Kohl B, Zumbach MS, et al. Hyperhomocyst(e) inemia and endothelial dysfunction in IDDM [J]. Diabetes care, 1998, 21(5):841-848.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部